SCHEMBL18619570

SCHEMBL18619570

CC(C)(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)CF

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 4/20 0.55
▸ CMA1 P23946 7/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ CASP2 P42575 1/20 0.46
▸ CASP4 P49662 1/20 0.46
▸ CASP5 P51878 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ CASP9 P55211 1/20 0.46
▸ CASP8 Q14790 1/20 0.46
▸ CASP10 Q92851 1/20 0.46
▸ DPP4 P27487 2/20 0.43
▸ DPP8 Q6V1X1 2/20 0.43
▸ DPP9 Q86TI2 1/20 0.43
▸ DPP7 Q9UHL4 1/20 0.43
▸ ELANE P08246 1/20 0.43
▸ ITGB3 P05106 1/20 0.42
▸ ITGA2B P08514 1/20 0.42
▸ ACE P12821 1/20 0.42
▸ OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22209365 0.91 MALT1 (0.64) MALT1CMA1ELANE
SCHEMBL18619572 0.91 MALT1 (0.64) MALT1CMA1ELANE
SCHEMBL22811073 0.91 MALT1 (0.64) MALT1CMA1ELANE
SCHEMBL18621052 0.91 MALT1 (0.64) MALT1CMA1ELANE
SCHEMBL22209464 0.91 MALT1 (0.57) MALT1CMA1DPP4DPP8DPP9
SCHEMBL18619636 0.89 MALT1 (0.55) MALT1CMA1DPP4DPP8ACE
SCHEMBL22209378 0.89 MALT1 (0.61) MALT1CMA1DPP4DPP8DPP9
SCHEMBL18619579 0.89 MALT1 (0.61) MALT1CMA1ELANE
SCHEMBL18619638 0.89 MALT1 (0.57) MALT1DPP4DPP8OPRM1OPRK1
SCHEMBL18619573 0.89 MALT1 (0.53) MALT1CMA1CASP3DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3341007-B1 MALT1 INHIBITORS AND USES THEREOF UNIV CORNELL (US) 2020-12-23 — — EP disclosed
US-10711036-B2 MALT1 inhibitors and uses thereof CORNELL UNIVERSITY (US) 2020-07-14 — — US disclosed
WO-2017040304-A1 MALT1 INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2017-03-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10711036-B2 MALT1 inhibitors and uses thereof MALT1, BCL3, BCL6 MALT1 1/4885CMA1 130/4885CASP1 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback